EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.

IF 2.9 3区医学 Q3 ENGINEERING, BIOMEDICAL

Expert Review of Medical Devices Pub Date : 2023-02-01 DOI:10.1080/17434440.2023.2174429

Elena Martínez-Plaza, Alberto López-de la Rosa, Alberto López-Miguel, Alfredo Holgueras, Miguel J Maldonado

{"title":"EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.","authors":"Elena Martínez-Plaza, Alberto López-de la Rosa, Alberto López-Miguel, Alfredo Holgueras, Miguel J Maldonado","doi":"10.1080/17434440.2023.2174429","DOIUrl":null,"url":null,"abstract":"Introduction: Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most prevalent lenses implanted. They incorporate a central orifice to avoid the need for iridotomy. The main difference between both ICL is the higher optical diameter zone provided by the EVO+, allowing a better quality of vision at night. This review aims to provide an overview of the current ICL models available for correcting myopia and myopic astigmatism.Areas covered: During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the implantation of central hole ICL lenses and the subjective perception of the patients implanted with these lenses. In addition, the safety and the potential complications associated with undergoing an EVO and EVO+ ICL implantation have been addressed.Expert opinion: Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future research could address minor issues currently not resolved.","PeriodicalId":12330,"journal":{"name":"Expert Review of Medical Devices","volume":"20 2","pages":"75-83"},"PeriodicalIF":2.9000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Medical Devices","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/17434440.2023.2174429","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 3

Abstract

Introduction: Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most prevalent lenses implanted. They incorporate a central orifice to avoid the need for iridotomy. The main difference between both ICL is the higher optical diameter zone provided by the EVO+, allowing a better quality of vision at night. This review aims to provide an overview of the current ICL models available for correcting myopia and myopic astigmatism.

Areas covered: During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the implantation of central hole ICL lenses and the subjective perception of the patients implanted with these lenses. In addition, the safety and the potential complications associated with undergoing an EVO and EVO+ ICL implantation have been addressed.

Expert opinion: Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future research could address minor issues currently not resolved.

查看原文本刊更多论文

EVO/EVO+ Visian植入式屈光体镜片用于矫正近视及近视伴散光。

导读:人工晶状体植入术是目前广泛应用的一种治疗屈光不正的方法。EVO和EVO+ Visian植入式Collamer lens (ICL)是目前最流行的两种植入式晶体。它们包括一个中心孔，以避免虹膜切开术的需要。两种ICL的主要区别是EVO+提供了更高的光学直径区域，允许夜间更好的视觉质量。本文综述了目前用于矫正近视和近视散光的ICL模型。研究领域:在过去的十年中，已经发表了100多篇分析EVO和EVO+镜头性能的科学论文。本文综述了中心孔人工晶体植入术后的客观视觉表现以及植入术患者的主观感觉。此外，还讨论了EVO和EVO+ ICL植入的安全性和潜在并发症。专家意见:屈光外科医生和接受ICL植入的候选人应该意识到中心孔ICL晶状体植入所提供的极好的安全性和视力效果。然而，未来的研究可以解决目前尚未解决的小问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Medical Devices 医学-工程：生物医学

CiteScore

5.90

自引率

3.20%

发文量

审稿时长

6-12 weeks

期刊介绍： The journal serves the device research community by providing a comprehensive body of high-quality information from leading experts, all subject to rigorous peer review. The Expert Review format is specially structured to optimize the value of the information to reader. Comprehensive coverage by each author in a key area of research or clinical practice is augmented by the following sections: Expert commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author''s most critical points In addition to the Review program, each issue also features Medical Device Profiles - objective assessments of specific devices in development or clinical use to help inform clinical practice. There are also Perspectives - overviews highlighting areas of current debate and controversy, together with reports from the conference scene and invited Editorials.